Association of SNPs-11377C/G in proximal promoter region of adiponectin gene with type 2 diabetes in Northern Chinese Han population

Journal of Clinical Rehabilitative Tissue Engineering Research

Volumn 11, Issue 34, 2007, Pages 6815-6818

  Shi, Xiao Hong ^a,b   Jin, Feng ^b   Wang, Li ^b   Yang, Ze ^a  

^a BEIJING HOSPITAL   (China)

^b INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; CYTOSINE; GUANOSINE;

ADULT; AGED; ARTICLE; BODY MASS; CHINESE; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

EID: 34548762084     PISSN: 16738225     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Hu E, Liang P, Spiegelman BM. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 1996;271(18):10697-10703
2. Berg AH, Combs TP, Du X, et al. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 2001;7: 947-953
3. Menzaghi C, Ercolino T, Salvemini L, et al. Multigenic control of serum adiponectin levels: evidence for a role of the APM1 gene and a locus on 14q13. Physiol Genomics 2004; 19(2):170-174
4. Yang WS, Chuang LM. Human genetics of adiponectin in the metabolic syndrome. J Mol Med 2006;84(2):112-121
5. Vasseur F, Meyre D, Froguel P. Adiponectin, type 2 diabetes and the metabolic syndrome: lessons from human genetic studies. Expert Rev Mol Med 2006;8(27):1-12
6. Jelena Zacharova, Jean-Louis Chiasson, Markku Laakso. The Common Polymorphisms (Single Nucleotide Polymorphism [SNP] +45 and SNP +276) of the Adiponectin Gene Predict the Conversion From Impaired Glucose Tolerance to Type 2 Diabetes. Diabetes 2005;54:893-899
7. World health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications, report of a WHO consultation. Geneva, World Health Organization 1999: 1-20
8. Yamauchi T, Kamon J, Minokoshi Y, et al. Adiponectin stimulates Glucose utilization and fatty-acid oxidation by activating AMP-activated proteinkinase. Nat Med 2002; 8:1288-1295
9. Kadowaki T, Yamauchi T, Kubota N, et al. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 2006; 116(7):1784-1792
10. Qi L, Doria A, Manson JE, et al. Adiponectin genetic variability, plasma adiponectin, and cardiovascular risk in patients with type 2 diabetes. Diabetes 2006;55:1512-1516
11. Matsuda M, Shimomura I, Sata M, et al. Role of adiponectin in preventing vascular stenosis: the missing link of adipo-vascular axis. J Biol Chem 2002;277:37487-37491
12. Chinese source.
13. Vionnet N, Hani EH, Dupont S, et al. Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-24. Am J Hum Genet 2000;67:1470-1480
14. Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adipose-specific: protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999;257:79-83
15. Hotta K, Funahashi T, Arita Y, et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000;20:1595-1599
16. Chinese source.
17. Amauchi T, Kamon J, Waki H, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001;7: 941-946
18. Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001;86: 1930-1935
19. Matsuzawa Y, Funahashi T, Kihara S, et al. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 2004;24: 29-33
20. Tschritter O, Fritsche A, Thamer C, et al. Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes 2003;52: 239-243
21. Fumeron F, Aubert R, Siddiq A, et al. Epidemiologic Data on the Insulin Resistance Syndrome (DESIR) Study Group. Adiponectin gene polymorphisms and adiponectin levels are independently associated with the development of hyperglycemia during a 3-year period: the epidemiologic data on the insulin resistance syndrome prospective study. Diabetes 2004;53: 1150-1157
22. Lindsay RS, Funahashi T, Hanson RL, et al. Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 2002;360: 57-58
23. Harvest F Gu, Abulaiti A, Ostenson CG, et al. Single nucleotide polymorphisms in the proximal promoter region of the adiponectin (APM1) gene are associated with type 2 diabetes in Swedish caucasians. Diabetes 2004;53 Suppl 1:S31-35
24. Vasseur F, Helbecque N, Dina C, et al. Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. Hum Mol Genet 2002; 11(21):2607-2614
25. Gibson F, Froguel P. Genetics of the APM1 locus and its contribution to type 2 diabetes susceptibility in French Caucasians. Diabetes 2004;53 (11):2977-2983
26. Schwarz PE, Govindarajalu S, Towers W, et al.Haplotypes in the promoter region of the ADIPOQ gene are associated with increased diabetes risk in a German Caucasian population Horm Metab Res 2006; 38(7):447-451
27. Schwarz PE, Towers GW, Fischer S, et al. Hypoadiponectinemia is associated with progression toward type 2 diabetes and genetic variation in the ADIPOQ gene promoter. Diabetes Care 2006;29(7):1645-1650
28. Bouatia-Naji N, Meyre D, Lobbens S.ACDC/adiponectin polymorphisms are associated with severe childhood and adult obesity. Diabetes 2006; 55(2):545-550